|
||
ARTICLE |
RIIb
CORRESPONDENCE Kenneth G.C. Smith: kgcs2{at}cam.ac.uk
Fc
RIIb is an inhibitory Fc receptor expressed on B cells and myeloid cells. It is important in controlling responses to infection, and reduced expression or function predisposes to autoimmunity. To determine if increased expression of Fc
RIIb can modulate these processes, we created transgenic mice overexpressing Fc
RIIb on B cells or macrophages. Overexpression of Fc
RIIb on B cells reduced the immunoglobulin G component of T-dependent immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced spontaneous systemic lupus erythematosus (SLE). In contrast, overexpression on macrophages had no effect on immune responses, CIA, or SLE but increased mortality after Streptococcus pneumoniae infection. These results help define the role of Fc
RIIb in immune responses, demonstrate the contrasting roles played by Fc
RIIb on B cells and macrophages in the control of infection and autoimmunity, and emphasize the therapeutic potential for modulation of Fc
RIIb expression on B cells in inflammatory and autoimmune disease.
globulin; CIA, collagen-induced arthritis; CII, type II collagen; ERK, extracellular signal-regulated kinase; FDC, follicular dendritic cell; GC, germinal center; M-NTG and -TG, macrophage nontransgenic and transgenic, respectively; NP, 4-hydroxyl-3-nitrophenyl acetyl; PC, phosphorylcholine; SLE, systemic lupus erythematosus. A.J. Cutler's present address is Histocompatibility and Immunogenetics, NHS Blood and Transplant, Colindale Centre, London NW9 5BG, England, UK.
R.A. Floto's present address is Cystic Fibrosis and Lung Defence Unit, Papworth Hospital NHS Foundation Trust, Cambridge CB23 3RE, England, UK.
| TABLE OF CONTENTS |
|